Imatinib Terminated Phase 1 Trials for Gastrointestinal Stromal Tumors Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00573404Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors